Skip to main content

Table 3

From: Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine

 

Loratadine Dissatisfied Segments – Severe Allergic Rhinitis

 

Converted to Fexofenadine N = 88 (weighted)

Converted to Desloratadine N = 35 (weighted)

Side Effects

  

   Sum of Adverse Events1

2.0**

1.35**

Symptom Relief

  

   EOD Failure – Nighttime Awakening1

2.93**

1.81**

   EOD Failure – Morning Symptoms1

3.74

3.62

   Onset of Relief2

4.34

4.58

   Coverage Period2

4.37**

5.15**

   Overall Symptom Relief2

4.92

5.34

Overall Satisfaction

  

   Continuation Intentions2

5.10

5.41

   Likelihood to Recommend2

4.66

5.32

   Overall Satisfaction with Current Rx2

4.67*

5.37*

   Satisfaction with Rx Change2

4.76

5.27

  1. *p < = .05 **p < = .01 1 Higher number reflects negative medication experience. 2 Higher number reflects positive medication experience.
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us